Fresenius Medical Care AG & Co. KGaA (FME) - Total Liabilities
Based on the latest financial reports, Fresenius Medical Care AG & Co. KGaA (FME) has total liabilities worth €17.76 Billion EUR (≈ $20.77 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore FME long-term investment intensity to see how much of total assets are deployed in long-term investments.
Fresenius Medical Care AG & Co. KGaA - Total Liabilities Trend (1998–2025)
This chart illustrates how Fresenius Medical Care AG & Co. KGaA's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Fresenius Medical Care AG & Co. KGaA assets under control.
Fresenius Medical Care AG & Co. KGaA Competitors by Total Liabilities
The table below lists competitors of Fresenius Medical Care AG & Co. KGaA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jfrog Ltd
NASDAQ:FROG
|
USA | $528.64 Million |
|
Sunoco LP
NYSE:SUN
|
USA | $12.30 Billion |
|
News Corp A
NASDAQ:NWSA
|
USA | $6.31 Billion |
|
Fuzhou Rockchip Electronics Co Ltd
SHG:603893
|
China | CN¥873.35 Million |
|
American Financial Group, Inc.
NYSE:AFG
|
USA | $21.16 Billion |
|
Aier Eye Hospital Group
SHE:300015
|
China | CN¥11.97 Billion |
|
Chongqing Sokon Ind Grp Co
SHG:601127
|
China | CN¥92.78 Billion |
|
Vedanta Limited
NSE:VEDL
|
India | Rs1.65 Trillion |
Liability Composition Analysis (1998–2025)
This chart breaks down Fresenius Medical Care AG & Co. KGaA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Fresenius Medical Care AG & Co. KGaA's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.57 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fresenius Medical Care AG & Co. KGaA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fresenius Medical Care AG & Co. KGaA (1998–2025)
The table below shows the annual total liabilities of Fresenius Medical Care AG & Co. KGaA from 1998 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €16.72 Billion ≈ $19.55 Billion |
-6.06% |
| 2024-12-31 | €17.80 Billion ≈ $20.81 Billion |
-6.83% |
| 2023-12-31 | €19.10 Billion ≈ $22.33 Billion |
-5.92% |
| 2022-12-31 | €20.30 Billion ≈ $23.74 Billion |
-0.41% |
| 2021-12-31 | €20.39 Billion ≈ $23.84 Billion |
+5.32% |
| 2020-12-31 | €19.36 Billion ≈ $22.63 Billion |
-1.78% |
| 2019-12-31 | €19.71 Billion ≈ $23.04 Billion |
+47.74% |
| 2018-12-31 | €13.34 Billion ≈ $15.60 Billion |
+1.08% |
| 2017-12-31 | €13.20 Billion ≈ $15.43 Billion |
-10.32% |
| 2016-12-31 | €14.72 Billion ≈ $17.20 Billion |
+7.00% |
| 2015-12-31 | €13.75 Billion ≈ $16.08 Billion |
+8.47% |
| 2014-12-31 | €12.68 Billion ≈ $14.82 Billion |
+28.42% |
| 2013-12-31 | €9.87 Billion ≈ $11.54 Billion |
-0.46% |
| 2012-12-31 | €9.92 Billion ≈ $11.60 Billion |
+12.07% |
| 2011-12-31 | €8.85 Billion ≈ $10.35 Billion |
+23.00% |
| 2010-12-31 | €7.20 Billion ≈ $8.41 Billion |
+17.28% |
| 2009-12-31 | €6.14 Billion ≈ $7.17 Billion |
-4.64% |
| 2008-12-31 | €6.43 Billion ≈ $7.52 Billion |
+10.51% |
| 2007-12-31 | €5.82 Billion ≈ $6.81 Billion |
-5.12% |
| 2006-12-31 | €6.14 Billion ≈ $7.17 Billion |
+81.94% |
| 2005-12-31 | €3.37 Billion ≈ $3.94 Billion |
+6.12% |
| 2004-12-31 | €3.18 Billion ≈ $3.72 Billion |
-5.71% |
| 2003-12-31 | €3.37 Billion ≈ $3.94 Billion |
-10.45% |
| 2002-12-31 | €3.76 Billion ≈ $4.40 Billion |
-13.65% |
| 2001-12-31 | €4.36 Billion ≈ $5.10 Billion |
+24.88% |
| 2000-12-31 | €3.49 Billion ≈ $4.08 Billion |
-5.77% |
| 1999-12-31 | €3.71 Billion ≈ $4.33 Billion |
+31.58% |
| 1998-12-31 | €2.82 Billion ≈ $3.29 Billion |
-- |
About Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arr… Read more